These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 27060367)

  • 1. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome.
    Zhao L; Yang W; Chen Y; Huang F; Lu L; Lin C; Huang T; Ning Z; Zhai L; Zhong LL; Lam W; Yang Z; Zhang X; Cheng C; Han L; Qiu Q; Shang X; Huang R; Xiao H; Ren Z; Chen D; Sun S; El-Nezami H; Cai Z; Lu A; Fang X; Jia W; Bian Z
    J Clin Invest; 2020 Jan; 130(1):438-450. PubMed ID: 31815740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.
    Kamp KJ; Cain KC; Utleg A; Burr RL; Raftery D; Luna RA; Shulman RJ; Heitkemper MM
    Biol Res Nurs; 2021 Jan; 23(1):65-74. PubMed ID: 32666807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
    Zhan K; Zheng H; Li J; Wu H; Qin S; Luo L; Huang S
    Biomed Res Int; 2020; 2020():3828249. PubMed ID: 33274207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls.
    Beinvogl BC; Manini ML; Camilleri M; Donato LJ; Harmsen WS; Absah I; Burch E; Schechter NL; Nurko S
    J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):859-865. PubMed ID: 33976086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
    Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.